title: Neostigmine, atropine, and glycopyrrolate: does neostigmine cross the placenta?
authors.affiliation: Department of Anesthesiology, College of Medicine, Little Rock, Arkansas 72205-7199, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Clark
authors.forename: M A
authors.initials: MA
authors.lastname: Brown
authors.forename: D L
authors.initials: DL
authors.lastname: Lattin
mesh_terms: D000759:Adjuvants, Anesthesia / Q000009:adverse effects* / Q000493:pharmacokinetics; D000328:Adult; D000768:Anesthesia, General; D001285:Atropine / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D005318:Fetal Heart / Q000187:drug effects; D006024:Glycopyrrolate / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008431:Maternal-Fetal Exchange; D009388:Neostigmine / Q000009:adverse effects* / Q000493:pharmacokinetics; D011247:Pregnancy; D011248:Pregnancy Complications / Q000601:surgery*
chemical_list: D000759:Adjuvants, Anesthesia; D009388:Neostigmine; D001285:Atropine; D006024:Glycopyrrolate